Although rare, male breast cancer is a significant health concern – accounting for approximately 1% of all breast cancer cases each year. Despite its rarity, the impact of a male breast cancer diagnosis can be life-altering, often presenting unique challenges due to late detection and limited research.

For 61-year-old Brad Whitelaw, his diagnosis was mildly familiar. Although his mother was diagnosed with breast cancer and passed away some time ago, genetic testing proved negative. With no additional risk factors, Brad began his journey of Stage 2 invasive ductal carcinoma after finding a lump just under his right nipple. 

“After completing an ultrasound of the area, my doctor, who never calls me unless something is wrong, asked me to come into his office and referred me to a surgeon. He confirmed my diagnosis, male breast cancer.”

Brad quickly met with the referred surgeon, where a lumpectomy was performed in March 2023 to remove the tumor and several lymph nodes. This was followed by five rounds of radiation and follow up testing every six months.

Despite receiving excellent access, medical care and emotional support from his care team in Niagara, the most difficult part of his treatment pertains to the drug treatments initially recommended by oncologists.

When initially screened, Brad was prescribed a daily pill and a monthly needle, which would be part of his care routine for a minimum of five years as a means to treat the possible reoccurrence of his breast cancer. 

Due to the current restrictions in Canada, Brad would not be fully covered for this treatment – it is only covered for females with breast cancer. For the injection alone, he would be required to pay approximately $48,000 out-of-pocket – plus the cost of the daily pill. 

“If I was a female with breast cancer, this treatment plan would have been fully covered by OHIP. It would not have cost me a thing”. Additionally, Brad would have been a ‘guinea pig’ for this treatment – as there is very little data on the success rate in men.

For patients like Brad, it is very difficult to make decisions on your health care when there is little research and resources available. Breast cancer is predominantly viewed as a women’s disease, which can perpetuate a lack of awareness and resources for male patients. As a result, clinical trials, support systems, and educational resources are often tailored to women, leaving men underrepresented and underserved. 

Breast Cancer Canada continues to advocate for equitable access to life-saving treatments for ALL Canadians. Brad’s story is a clear indication of why advancements in research are necessary. Breast cancer affects everyone, not just women.

Donate to the progress today by visiting breastcancerprogress.ca